Search

Issue
Title
Authors
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S.V., Biryukova E.V., Solovievа I.V.
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I.Y., Bagriy A.E., Mikhailichenko E.S., Kutya A.E., Sovpel Y.A.
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.Y.
Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin
Biryukova E.V.
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E.V., Shinkin M.V., Morozova I.A.
Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus
Demidov N.A.
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.G.
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V.I., Shatalova O.V., Klykova M.S., Stetsky N.P.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I.Y., Boeva V.V.
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I.B., Gubachikova A.M., Aramisova L.S., Anaeva L.A., Abdul Moati H.A.
Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age
Markina J.M.
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
Antsiferov M.B., Antsiferova D.M., Koteshkova O.M., Demidov N.A.
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Demidov N.A.
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K.S., Gatina A.I., Gorbunova Y.S., Demidov N.A., Ivanenko T.S., Kolesnikova M.I., Lapteva O.A., Morozova I.V., Parshina V.A., Presnyakova O.Y., Smirnova E.Y., Smirnova N.P., Startseva M.A., Khamrazhanov Z.A., Kholmskaya N.I.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A.G., Bagriy A.E., Prikolota A.V., Prikolota O.A., Mikhailichenko E.S., Golodnikov I.A., Bagriy O.N.
Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus
Demicheva T.P.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
Smirnova E.Y.
Modern possibilities for assessing glycemia in diabetic patients
Chernikova N.A., Degtyareva E.I.
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O.A., Torshin I.Y., Limanova O.A., Grishina T.R., Gromov A.N.
News of medicine
Kudinova S.
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M.B., Zilov A.V., Koteshkova O.M., Demidov N.A.
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A.E., Shchukina E.V., Efremenko V.A., Mikhailichenko E.S., Suprun E.V.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.Y.
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.S.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A.S., Valitov B.I., Chernikova N.A., Antsiferov M.B.
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Chemikova N.A.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A.F., Sharonova L.A., Verbovaya N.I., Demidova D.V., Kapishnikov A.V.
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.Y.
SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mkrtumyan A.M., Mkrtumyan A.M.
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
Chernikova N.A., Knyshenko O.A., Ivanova L.P.
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.A.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Novikova M.S., Demidov N.A.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A.N., Litvinova D.V., Rozhkov N.I., Kiyaev A.V.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V.A., Peterkova V.A.
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I.V., Nechaeva G.I., Korennova O.Y., Druk I.V., Nechayeva G.I., Korennova O.Y.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.Y.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N.I., Panenko S.O., Golubeva A.O.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T.A., Salukhov V.V., Zemlyanoy A.B., Chebykina O.E.
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L.Y., Andreeva L.S., Davydova A.V., Chugunova E.V., Tokareva N.P., Molodtsova N.Y.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N.A., Knyshenko O.A.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K.V., Tanashyan M.M., Maksimova M.Y., Shakhparonova N.V., Romantsova T.I.
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Verbovoy A.F., Pashentseva A.V., Verbovaya N.I., Kosareva O.V.
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.B.
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.B.
Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa
Galstyan G.R.
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N.A., Ivanova L.P., Abaeva F.T.
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N.V., Shamkhalova M.S.
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A.S., Tertychnaya E.A.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E.E., Rashid M.A., Antsiferov M.B.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antciferov M.B.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y.V., Biryukova E.V.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V.V., Chazova I., Fomin V.
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M.B., Antsiferov M.
The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus
Shevkunova N.A., Vorobyov M.V., Gushchin V.V.
Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»
Antsiferov M.B., Galstyan G.R.
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
Izhbuldina G.I., Novikova L.B.
Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register)
Demidov N.A., Mishra O.A., Antsiferov M.B.
NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Demidova T.Y.
Diabetic distal polyneuropathy: the principles of diagnostics and therapy
Komelyagina E.Y., Antsiferov M.B.
Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients
Kovrigina E.V., Tyulganova V.L.
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
Kalashnikova M.F., Zilov A.V., Yazykova D.R., Likhodey N.V., Fadeev V.V.
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Bakulin I.G., Vinnytskaya E.V., Sandler Y.G., Keiyan V.A., Rodionova S.V.
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.M.
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.V.
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.S.
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E.V., Danilova T.B.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I.V., Romantsova T.I., Glinkina I.V., Romantsova T.I.
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E.V., pl?midmagidsid Y.h.
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
Antsiferov M.B., Koteshkova O.M., Kleimenova S.A., Antsiferov M.B., Koteshkova O.M., Kleymenova S.A.
Common bean (Phaseolus vulgaris L.)/
Samylina I.A., Sorokina A.A., Pyatigorskaya N.V., Samylina I., Sorokina A., Pyatigorskaya N.
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Dukhareva O.V., Demidov N.A., Novikova M.S.
Carbohydrate metabolism disorders and osteoporosis
Alekseeva N.S.
Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes
Shchukina E.V., Gromenkov V.D., Suprun Y.V., Mykhailichenko E.S., Beryozova E.V., Bagriy V.A., Golodnikov I.A.
Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs
Mkrtumyan A.M., Markova T.N.
The many faces of vitamin D
Verbovoy A.F., Dolgikh Y.A., Verbovaya N.I.
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)
Demidov N.A., Mishra O.A., Antsiferov M.B.
Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism
Verbovoy A.F., Lomonova T.V., Sharonova L.A.
Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus
Fedorchenko Y.L., Martynyuk M.V.
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.V.
Effect of glucagon-like peptide-1 receptor agonist on cardiovascular risk markers in patients with type 2 diabetes mellitus
Mkrtumyan A.M., Podachina S.V., Sviridova M.I.
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O.M., Molina L.P.
Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'
Pashentseva A.V., Verbovoy A.F.
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.V.
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M.B., Schemthaner G., Ametov A.S.
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Dorofeeva L.G.
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A.S., Brashchenkova A.V.
METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA
Verbovoy A.F., Vorozhtsova E.I., Orlova T.N.
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N.A., Prudnikova M.A., Chernikova N.A., Prudnikova M.A.
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
Antsiferov M.B., Antsiferov M.B.
Insulin resistance and heart diseases: is there a relationship?
Drapkina O.M., Smirin V.I., Ivashkin V.T., Drapkina O.M., Smirin V.I., Ivaschkin V.T.
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N.A., Martirosyan N.S., Valeeva F.V.
Obesity: an invisible disease
Verbovoy A.F., Dolgikh Y.A., Verbovaya N.I., Lomonova T.V.
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A.S., Tertychnaya E.A.
Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice
Markova T.N.
The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)
Antsiferov M.B., Kvasnikov B.B.
Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus
Sorokina Y.A., Zanozin A.V., Zanozina O.V., Runov G.P.
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M.B., Fadeev V.V., Morgunova T.B.
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.B.
1 - 100 of 177 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies